APA

Boitano S., Hoffman J., Flynn A. N., Asiedu M. N., Tillu D. V., Zhang Z., Sherwood C. L., Rivas C. M., DeFea K. A., Vagner J. & Price T. J. (2015). The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo. : British journal of pharmacology.

Chicago

Boitano Scott, Hoffman Justin, Flynn Andrea N, Asiedu Marina N, Tillu Dipti V, Zhang Zhenyu, Sherwood Cara L, Rivas Candy M, DeFea Kathryn A, Vagner Josef and Price Theodore J. 2015. The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo. : British journal of pharmacology.

Harvard

Boitano S., Hoffman J., Flynn A. N., Asiedu M. N., Tillu D. V., Zhang Z., Sherwood C. L., Rivas C. M., DeFea K. A., Vagner J. and Price T. J. (2015). The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo. : British journal of pharmacology.

MLA

Boitano Scott, Hoffman Justin, Flynn Andrea N, Asiedu Marina N, Tillu Dipti V, Zhang Zhenyu, Sherwood Cara L, Rivas Candy M, DeFea Kathryn A, Vagner Josef and Price Theodore J. The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo. : British journal of pharmacology. 2015.